fda approval tirzepatide weight loss for Zepbound: FSU researcher available for context on newly approved treatment is tirzepatide fda approved for

Food and Drug Administration (FDA) has warned against the use of GLP-1 RA by individuals with personal or family history of medullary thyroid cancer and hereditary conditions associated with this type of cancer. With this in mind, investigators evaluated whether people with type 2 diabetes who take GLP-1 RAs are at a higher risk of developing thyroid cancer compared with those taking other common diabetes medications

Evidence on GLP1 and Dementia Risk: Current Studies Research into GLP1 dementia risk is still emerging

Comp Biochem Physiol Part B Biochem Mol Biol (2020) 240:110354

Side Effects When you start taking the medication, you might feel sick to your stomach, throw up, have diarrhea, stomach pain, or not feel hungry

If you use oral contraceptive pills, its important to know that GLP-1s decrease the efficacy of birth control pills, Kadosh explained